Clinical Trial Update: Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a pancreatic enzyme product in pediatric participants with cystic fibrosis and exocrine pancreatic insufficiency has completed, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Pancrelipase (pancrelipase)

Snippet

Sponsor: Forest Laboratories | Conditions: Cystic Fibrosis, Exocrine Pancreatic Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2014-04-04